Clinical Trial Results:
            A Pilot study to evaluate the Efficacy of GFT505 (80mg) orally administered once daily for 8 weeks on insulin sensitivity and hepatic glucose production using a glucose clamp technique and Safety in patients with insulin resistance and abdominal obesity.
A Multicentre, Randomised, Single Blind, Placebo-Controlled, cross over study.
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2010-023219-32 | 
    Trial protocol  | 
        FR | 
    Global completion date  | 
        
                                    21 Nov 2011
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    03 Dec 2021
                             
         | 
    
    First version publication date  | 
        
                                    03 Dec 2021
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                GFT505-210-6_Clinical report synopsis | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.